Hepatitis C Knowledge and Recent Diagnosis Affect Hepatitis C Treatment Willingness in Persons Living With HIV

被引:1
|
作者
Cachay, Edward R. [1 ]
Torriani, Francesca J. [1 ]
Hill, Lucas [2 ]
Rajagopal, Amutha [1 ]
Yin, Jeffrey [2 ]
Bamford, Laura [1 ]
Mathews, William C. [3 ]
机构
[1] Univ Calif San Diego, Div Infect Dis & Global Publ Hlth, Dept Med, San Diego, CA USA
[2] Univ Calif San Diego, Owen Clin Unit, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA USA
[3] Univ Calif San Diego, Dept Med, San Diego, CA USA
关键词
health literacy; HCV knowledge; HIV literacy; treatment willingness; and HIV; HEALTH LITERACY; BARRIERS; PROJECT; CARE;
D O I
10.1097/QAI.0000000000002643
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: We assessed the impact of health literacy and hepatitis C (HCV) knowledge on HCV treatment willingness among people living with HIV (PLWH) at an academic HIV clinic. Methods: Cross-sectional analysis of PLWH coinfected with HCV who completed health literacy, HIV literacy, and HCV knowledge inventories. We estimated the prevalence of low health literacy, HIV knowledge, and HCV knowledge sampled from 3-comparison groups: PLWH not referred for HCV, referred but who "not showed" to the HCV clinic, and referred and attended the HCV clinic. We used mixed-model linear and logistic regression to ascertain predictors of low health literacy, HIV knowledge, HCV knowledge, and predictors of willingness to start HCV treatment. Results: We enrolled 151 PLWH; 17% were female, 38% non-White, and 60% without a high-school education. Approximately, 68% were men who have sex with men, of whom 62% used intravenous drugs. The prevalence of low health, HIV knowledge, and HCV knowledge was 10%, 32%, and 29%, respectively. Predictors of low health literacy were being Hispanic, cirrhotic, and not completing high-school education. Low HCV knowledge was observed in female, non-White, and those diagnosed with HCV for a decade. In adjusted analyses, PLWH living with HCV for a decade (OR: 0.23) were less likely to be very willing to be treated for HCV. By contrast, those with high HCV knowledge were more likely to be very willing to receive treatment (OR: 1.27). Conclusion: Low HCV knowledge and living with HCV for at least a decade are under-recognized negative predictors for PLWH's willingness to receive HCV treatment.
引用
收藏
页码:E159 / E166
页数:8
相关论文
共 50 条
  • [31] Attitudes and potential barriers towards hepatitis C treatment in patients with and without HIV coinfection
    Allyn, P. R.
    O'Malley, S. M.
    Ferguson, J.
    Tseng, C. H.
    Chew, K. W.
    Bhattacharya, D.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2018, 29 (04) : 334 - 340
  • [32] Factors That Influence an HIV Coinfected Patient's Decision to Start Hepatitis C Treatment
    Osilla, Karen Chan
    Ryan, Gery
    Bhatti, Laveeza
    Goetz, Matthew
    Witt, Mallory
    Wagner, Glenn
    AIDS PATIENT CARE AND STDS, 2009, 23 (12) : 993 - 999
  • [33] Knowledge About Hepatitis-C Among Methadone Maintenance Treatment Patients in Israel
    Cohen-Moreno, Rinat
    Schiff, Miriam
    Levitt, Shabtay
    Bar-Hamburger, Rachel
    Strauss, Shiela
    Neumark, Yehuda
    SUBSTANCE USE & MISUSE, 2010, 45 (1-2) : 58 - 76
  • [34] The Hepatitis C treatment experience: Patients' perceptions of the facilitators of and barriers to uptake, adherence and completion
    Sublette, Victoria A.
    Smith, Sian K.
    George, Jacob
    McCaffery, Kirsten
    Douglas, Mark W.
    PSYCHOLOGY & HEALTH, 2015, 30 (08) : 987 - 1004
  • [35] Reliability and predictive validity of a hepatitis-related symptom inventory in HIV-infected individuals referred for Hepatitis C treatment
    Cachay, Edward R.
    Wyles, David L.
    Goicoechea, Miguel
    Torriani, Francesca J.
    Ballard, Craig
    Colwell, Bradford
    Gish, Robert G.
    Mathews, William C.
    AIDS RESEARCH AND THERAPY, 2011, 8
  • [36] Prevalence and risk factors for patient-reported joint pain among patients with HIV/Hepatitis C coinfection, Hepatitis C monoinfection, and HIV monoinfection
    Ogdie, Alexis
    Pang, Wyki Gina
    Forde, Kimberly A.
    Samir, Bhangle D.
    Mulugeta, Lakeisha
    Chang, Kyong-Mi
    Kaplan, David E.
    Amorosa, Valerianna K.
    Kostman, Jay R.
    Reddy, Rajender K.
    Schumacher, Ralph H.
    Lo Re, Vincent, III
    BMC MUSCULOSKELETAL DISORDERS, 2015, 16
  • [37] Community-Based Point-of-Diagnosis Hepatitis C Treatment for Marginalized Populations
    Morris, Meghan D.
    Mcdonell, Claire
    Luetkemeyer, Annie F.
    Thawley, Robert
    Mckinney, Jeff
    Price, Jennifer C.
    JAMA NETWORK OPEN, 2023, 6 (10) : E2338792
  • [38] Peer-facilitated treatment access for hepatitis C: the Live Hep C Free project
    Silano, Julia A.
    Treloar, Carla
    Leadbeatter, Kyle
    Davidson, Sandy
    Doidge, Justine
    HARM REDUCTION JOURNAL, 2022, 19 (01)
  • [39] Knowledge and attitudes about hepatitis C virus (HCV) infection and its treatment in HCV mono-infected and HCV/HIV co-infected adults
    Chen, E. Y.
    North, C. S.
    Fatunde, O.
    Bernstein, I.
    Salari, S.
    Day, B.
    Jain, M. K.
    JOURNAL OF VIRAL HEPATITIS, 2013, 20 (10) : 708 - 714
  • [40] Willingness to participate in hepatitis C vaccine trials among socially marginalized people who use drugs
    Yakovenko, Igor
    Hyshka, Elaine
    Tyrrell, Lorne
    Wild, T. Cameron
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2019, 101 : 67 - 71